Daily News Briefs

Candela Corp., a Wayland, Mass., maker of lasers for medical and cosmetic treatments, announced it has received clearance from the FDA to market its Smoothbeam diode laser for the treatment of the skin condition sebaceous hyperplasia, in addition to its previously approved uses. . . . Honeywell announced that the Boeing Co. has selected its Astreon LED systems for exterior lighting on the new 7E7 Dreamliner aircraft, for which is has already provided the navigation package, crew information system/management system (CIS/MS) and flight-control electronic. Together, the systems have a potential value of more than $2.6 billion for Honeywell over the life of the 7E7 program. "LEDs have dramatically longer lives than traditional lights, so Astreon lights will provide airlines a welcome reduction in operating costs," said Frank Daly, president of Honeywell's Air Transport Systems. The contract provides for incorporation of Astreon anti-collision and navigation lighting systems on all 7E7 aircraft. . . . Jmar Technologies Inc. has promoted its vice president of business development, John Ricardi, to vice president of sensor products. He will be in charge of launching BioSentry, a laser-based, early-warning system for detecting and classifying potentially harmful microorganisms in water supplies. David L. McCarty has joined Jmar as vice president of business development. He was formerly president of Aquionics Inc., a nonchemical water purification company. . . . Light Sciences, a Seattle company developing light infusion technology (Litx), has appointed ophthalmologist and macular degeneration specialist Lawrence A. Yannuzzi to its scientific advisory board. Litx involves activating the drug talaporfin sodium (LS11) with light from an LED-based light infusion device. Clinical trials in Europe have been conducted and are planned for the US; potential applications include treating cancer and cardiovascular and eye diseases.